Five Definium Therapeutics executives sell stock in the same week
CEO, CFO, chief legal officer, chief commercial officer and chief medical officer all filed insider sales within days of each other.
Definium Therapeutics CEO Robert Barrow sold $1.15 million in shares, part of a wave of insider sales from at least five top executives at the company this week.
BREAKING STORYBEARISH